Anti-MuSK antibodies are found in 1%–10% of MG patients and are predominantly of the IgG4 subclass, which cannot activate complement; additionally, since these antibodies are functionally monovalent, they cannot induce antigen modulation (Huijbers et al., 2013). Here, MUSK is linked to myasthenia gravis.